Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 1 -10 of 22 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		Phase III Chemotherapy with IPP, IPP/ADR and CIA (IPP/ADR/CCNU) for Extensive non-Oat Cell Lung Carcinoma (Summary last modified 06/97)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Completed				no age specified				NCI				SWOG-7701


2.		Phase III Vitamin C vs Placebo in Patients with Advanced Colorectal Cancer Who Have Had No Prior Immunosuppressive Therapy

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				no age specified								MAYO-790602

Last Modified: 10/1/1988


3.		Study of the Effect of Nutritional Intervention on Esophageal Cancer in Linxian, People's Republic of China (Summary Last Modified 10/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Prevention				Completed				40 to 69								DCPC-CPSB-11204

Last Modified: 6/1/1991


4.		Phase III Randomized, Double-Blind Study of Multiple Vitamins at the Recommended Daily Allowance (RDA) vs Multiple Vitamins at the RDA plus High-Dose Vitamins A, B6, C, and E in Patients with Transitional Cell Carcinoma of the Bladder (Summary Last Modified 06/91)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Supportive care				Closed				any age								WVU-11715 NCI-V91-0025

Last Modified: 10/15/2007 First Published: 7/1/2000


5.		Phase I/II Study of Arsenic Trioxide Plus Ascorbic Acid in Patients With Recurrent or Refractory Multiple Myeloma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Completed				Over 18				NCI				SCCC-20010 SCCC-NCI-43, NCI-43, NCT00006021, 43


6.		Phase I/II Study of High-Dose Ascorbic Acid Potentiation of Alkylating Agents in Children with Advanced Cancer in Relapse

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				under 18								MDA-P-7901n


7.		Velcade, Trisenox, Vitamin C and Melphalan for Myeloma Patients

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Treatment				Closed				75 and under				Other				2005-0893 NCT00469209


8.		Phase II Ifosfamide Chemotherapy for Resistant Disseminated Malignant Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified				NCI				SWOG-7813


9.		Phase II Induction and Maintenance Combination Chemotherapy with IHOP (ADR/IPP/PRED/VCR) for Acute Lymphocytic Leukemia in Relapse

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				under 75				NCI				SWOG-7842


10.		Phase II Induction with High-Dose Prednisone plus VCR/MTX Followed by Aggressive Consolidation Chemotherapy for Refractory non-Hodgkin's Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				no age specified								NCI-D81-035-695 OSU-IOU-8107

Select All on One Page


					1 2 3 Next >

| | | | | | | |

A Service of the National Cancer Institute